President's Message
News Release
September 24, 2024
|
Press Release
Announcement of Marketing Authorization Transfer for Rabipur Intramuscular Injection
July 03, 2023
|
Updated Who we are
April 13, 2023
|
Press Release
Announcement for Initiation of Phase III Trial of Glycerol Phenylbutyrate in Urea Cycle Disorders in Japan
January 13, 2023
|
Updated organization chart
May 23, 2022
|
Announcement of exclusive license agreement for development, manufacturing and sale of glycerol phenylbutyrate in Japan